Xeris Pharmaceuticals logo
Xeris Pharmaceuticals XERS
$ 3.48 1.91%

Quarterly report 2024-Q3
added 11-08-2024

report update icon

Xeris Pharmaceuticals Income Statement 2011-2024 | XERS

Annual Income Statement Xeris Pharmaceuticals

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Market Cap

343 M 182 M 188 M 234 M 155 M 180 M - - - - - - -

Shares

138 M 136 M 79 M 46.1 M 26.1 M 12 M - - - - - - -

Historical Prices

2.49 1.34 2.38 5.45 3.56 10 - - - - - - -

Net Income

-62.3 M -94.7 M -123 M -91.1 M -126 M -60.1 M -26.6 M -13.2 M - - - - -

Revenue

164 M 110 M 49.6 M 20.4 M 2.72 M 2.46 M 1.56 M 1.08 M - - - - -

Cost of Revenue

28.6 M 22.6 M 13.3 M 9.33 M - - - - - - - - -

Gross Profit

- - - 11.1 M 1.12 M 2.42 M 1.55 M 1.07 M - - - - -

Operating Income

-44 M -81.9 M -115 M -83.5 M - - - - - - - - -

Interest Expense

26.6 M 14.1 M 7.18 M 10.7 M - - - - - - - - -

EBITDA

-42.5 M -80.5 M -114 M -82.1 M -121 M -59 M -26.5 M -13.1 M - - - - -

Operating Expenses

- - - 94.7 M 123 M 61.8 M 28.2 M 14.3 M - - - - -

General and Administrative Expenses

146 M 138 M 126 M 73.7 M 63.1 M 21.1 M 8.02 M 4.06 M - - - - -

All numbers in USD currency

Quarterly Income Statement Xeris Pharmaceuticals

2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Shares

149 M 148 M 141 M 138 M 138 M 137 M 137 M 136 M 136 M 136 M 135 M 125 M 66.5 M 66.4 M 61.2 M 59.6 M 46.1 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Net Income

-15.7 M -15 M -19 M - -12.2 M -19.8 M -16.8 M - -21.8 M -26.2 M -33.7 M - -26 M -27.5 M -18.4 M - -16 M -24.1 M -29.2 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Revenue

54.3 M 48.1 M 40.6 M - 48.3 M 38 M 33.2 M - 29.7 M 25.3 M 22.1 M - 11.1 M 8.91 M 8.2 M - 9.4 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Cost of Revenue

13.6 M 7.79 M 5.97 M - 8.2 M 7.56 M 5.32 M - 5.26 M 4.81 M 6.27 M - 3.22 M 3.38 M 1.83 M - 2.83 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Gross Profit

- - - - - - - - - - - - 7.84 M - - - 6.62 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Income

-12.9 M -8.19 M -14.2 M - -4.91 M -16 M -13.3 M - -18.8 M -18.9 M -29.1 M - -24.4 M -25.8 M -16.7 M - -13.7 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Interest Expense

-6.17 M -6.07 M 7.03 M - -7.61 M -4.54 M 6.22 M - 3.99 M 3.45 M 3.52 M - 1.8 M 1.8 M 1.79 M - 2.33 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

EBITDA

-10.2 M -5.48 M -13.9 M - -2.2 M -13.3 M -12.9 M - -16.1 M -16.2 M -28.8 M - -23.4 M -25.1 M -16.4 M - -12.7 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Expenses

- - - - - - - - - - - - 32.2 M - - - 20.4 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

General and Administrative Expenses

45 M 40 M 38.4 M - 37.3 M 37.6 M 33.6 M - 34.5 M 33 M 35.9 M - 26.5 M 25.9 M 19.1 M - 16.5 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency